Permanent Urethral Stents for Detrusor Sphincter Dyssynergia

McInerney, P. D.; Vanner, T. F.; Harris, S. A. B.; Stephenson, T. P.

doi:10.1111/j.1464-410x.1991.tb15137.x

Cited by 48 publications

(8 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… implanted the first eight metal stents in patients with a urethral stricture. Subsequently, these stents have been widely used in other urological diseases: BPH, detrusor sphincter dyssynergia and ureteric strictures, both of malignant or benign origin .…”

Section: Introductionmentioning

confidence: 99%

The Wallstent: long‐term follow‐up of metal stent placement for the treatment of benign ureteroileal anastomotic strictures after Bricker urinary diversion

Campschroer

Lock

et al. 2014

BJU International

View full text Add to dashboard Cite

ObjectiveTo evaluate the long-term follow-up (primary and secondary patency) of metal stent placement in benign ureteroileal anastomotic strictures after Bricker urinary diversion and to compare the failed treatment group with the group of successfully treated patients to search for predisposing factors of stent failure. Patients and MethodsFor patients treated since 1989 for benign ureteroileal strictures after Bricker urinary diversion with end-to-side anastomosis, we retrospectively collected data on clinical history, stent placement, auxiliary measures and patency rates from a prospectively kept database. ResultsIn all, 49 patients (mean age 64 years) underwent 56 metal stent procedures. Placement of the stent was possible in all patients. Stent patency without auxiliary treatment remained adequate in 23 cases (primary patency of 41.1%, mean follow-up 37.7 months). A secondary treatment was successfully performed in 11 patients who had stent obstruction, mostly caused by hyperplastic reaction, encrustation, or migration of the stent. The secondary patency rate was 60.7% (mean follow-up 55.8 months), comparable with patency rates of 36-100% described in literature with mostly small patient groups and much shorter follow-up periods. ConclusionTo the best of our knowledge we report the largest series of metal stenting in benign ureteroileal anastomotic strictures with the longest follow-up. We show that placement of a metal stent can lead to a permanent de-obstruction in approximately six out of 10 patients with preservation of renal function.

show abstract

Section: Introductionmentioning

confidence: 99%

The Wallstent: long‐term follow‐up of metal stent placement for the treatment of benign ureteroileal anastomotic strictures after Bricker urinary diversion

Campschroer

Lock

et al. 2014

BJU International

View full text Add to dashboard Cite

show abstract

“…They reported a low complication rate and high success in treatment of DSD. [13][14][15] When a foreign object is placed inside the body, there is always concern regarding its long term safety and its potential for carcinogenicity. The European experience with the stent extends up to 3 years and there have been no reported complica tions.13,14 We have not observed any adverse effects during our short term follow up; however, long term observation is necessary to establish its safety.…”

Section: Discussionmentioning

confidence: 99%

Urolume urethral wallstent in the treatment of detrusor sphincter dyssynergia

et al. 1994

View full text Add to dashboard Cite

Neuropathic voiding dysfunction with detrusor sphincter dyssynergia (DSD) is a common complication of spinal cord injury (SCI) and multiple sclerosis. Sphinc terotomy has been recommended for treatment of DSD if the patient lacks the ability to do intermittent self catheterization. We report our preliminary results of the Urolume urethral wallstent for the treatment of DSD in 10 patients. The insertion technique proved simple, with a short hospital stay and low morbidity; however, its long term safety has not yet been established.

show abstract

“…The Wallstent has been applied for urethral stricture treatment [ 1, 2, 4, 7 -9], detrusor sphincter dyssynergia [12], patients with spinal injuries [13], and in the prostatic urethra [5,14]. The Wallstent has been applied for urethral stricture treatment [ 1, 2, 4, 7 -9], detrusor sphincter dyssynergia [12], patients with spinal injuries [13], and in the prostatic urethra [5,14].…”

Section: Discussionmentioning

confidence: 99%